The suggested reasons consist in the enhancer role of 17β-estradiol on adrenocortical cell proliferation, in the increased estrogen-related receptor α expression in cancer tissues and insulin-like growth factor 2 stimulation of ACC cell proliferation [34,35,36,37]. Here, IGF2 is linked to cancer.